What is Lisdexamfetamine?
Category: Prescription Drugs
Most popular types: Vyvanse Elvanse
Lisdexamfetamine is a central nervous system stimulant. It works by changing the amounts of certain natural substances in the brain. It is used as part of a treatment program for attention deficit hyperactivity disorder (ADHD).
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Attention deficit/hyperactivity disorder | 678 | 182 | |
| Problems concentrating | 143 | 86 | |
| Fatigue | 128 | 70 | |
| Attention deficit disorder | 40 | 19 | |
| Binge eating disorder | 19 | 10 | |
| Lack of motivation | 16 | 18 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 24 | |
| Moderate | 61 | |
| Mild | 97 | |
| None | 94 |
Commonly reported side effects and conditions associated with Lisdexamfetamine
| Side effect | Patients | Percentage |
|---|---|---|
| Decreased appetite | 36 | |
| Dry mouth | 16 | |
| Tachycardia (fast heart rate) | 15 | |
| Anxious mood | 14 | |
| Headaches | 13 | |
| Insomnia | 11 |
Why patients stopped taking Lisdexamfetamine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 54 | |
| Side effects too severe | 51 | |
| Other | 36 | |
| Doctor's advice | 33 | |
| Expense | 31 | |
| Change in health plan coverage | 18 | |
| Personal research | 17 | |
| Course of treatment ended | 1 |
Duration
Stopped taking Lisdexamfetamine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 30 | |
| 1 - 6 months | 34 | |
| 6 months - 1 year | 18 | |
| 1 - 2 years | 30 | |
| 2 - 5 years | 27 | |
| 5 - 10 years | 7 |
What people switch to and from
Patients started taking Lisdexamfetamine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Amphetamine-Dextroamphetamine (Adderall) | 67 | |
| Methylphenidate (Ritalin) | 37 | |
| Modafinil (Provigil) | 7 | |
| Dextroamphetamine (Dexedrine) | 6 | |
| Atomoxetine (Strattera) | 4 |
Patients stopped taking Lisdexamfetamine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Amphetamine-Dextroamphetamine (Adderall) | 54 | |
| Methylphenidate (Ritalin) | 10 | |
| Atomoxetine (Strattera) | 5 | |
| Dextroamphetamine (Dexedrine) | 4 | |
| Dexmethylphenidate (Focalin XR) | 3 |
Last updated: